Pharmacovigilance And Drug Safety Software Market To Witness A Significant Growth Of USD 17.3 Billion By 2030Posted by Neha Bora on May 11th, 2023 San Francisco, 11 May 2023: The Report Pharmacovigilance And Drug Safety Software Market Size, Share & Trends Analysis Report By Functionality, By Delivery Mode (On Premise, On Demand), By End-use, By Region, And Segment Forecasts, 2023 - 2030 The global pharmacovigilance and drug safety software market size is anticipated to reach USD 17.3 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a lucrative CAGR of 10.30% from 2023 to 2030. The key factors driving the market growth include the increasing need to track and manage adverse drug reactions (ADR), comply with regulatory norms, increase adoption by end-users, interoperability, and product upgrades by key companies. In February 2022, Oracle’sArgus (for safety management) and Clinical One (for clinical trial management) were implemented by Clinixir—a Thailand-based CRO. Various end-users such as pharmaceutical, and biotechnology companies, are adopting pharmacovigilance and drug safety software for cost reduction and minimizing operational expenses by gradually shifting from being fully integrated pharmaceutical companies to sharing costs by collaborating with service providers. Outsourcing helps increase internal resource flexibility, improves timelines, and results in better outcomes in the short as well as long term. Outsourcing also helps achieve better pharmacovigilance (PV) through regulatory compliance, higher quality, better productivity, and improved strategic outcomes. This is expected to fuel market growth. Pharmacovigilance and drug safety software vendors, in an attempt to ensure sustainability, are providing customized and end-to-end solutions to meet consumer needs. These vendors are also incorporating integrated technologies such as electronic data capture, AI, and interoperability, among others to enhance their offerings. Moreover, the combined pressures of volume, cost, and heightened demand for analytics are propelling industry stakeholders to adopt advanced technology to support their pharmacovigilance activities. Also, the fact that service providers are now operating via a flexible and variable pricing structure and achieving operational excellence through constant product updates is expected to boost usage rates over the forecast period. Access Research Report of Pharmacovigilance And Drug Safety Software Market @ https://www.grandviewresearch.com/industry-analysis/pharmacovigilance-software-market Pharmacovigilance And Drug Safety Software Market Report Highlights
List of Key Players in the Pharmacovigilance And Drug Safety Software Market
Access Press Release of Pharmacovigilance And Drug Safety Software Market @ https://www.grandviewresearch.com/press-release/global-pharmacovigilance-software-market Like it? Share it!More by this author |